MaxCyte Dividends and Buybacks

Dividend criteria checks 0/6

MaxCyte does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.6%

Buyback Yield

Total Shareholder Yield-0.6%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

MaxCyte expands capacity by relocating to new HQ in Maryland

Sep 21

MaxCyte signs strategic platform with LG Chem

Jul 12

MaxCyte: Enabling Next-Generation Cell Based Therapies, Attractive Risk-Return Profile

Sep 06

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MXCT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MXCT's dividend payments have been increasing.


Dividend Yield vs Market

MaxCyte Dividend Yield vs Market
How does MXCT dividend yield compare to the market?
SegmentDividend Yield
Company (MXCT)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Life Sciences)0.5%
Analyst forecast (MXCT) (up to 3 years)0%

Notable Dividend: Unable to evaluate MXCT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MXCT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MXCT's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MXCT has not reported any payouts.


Discover strong dividend paying companies